Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 089: AZT/3TC/Loviride (AVANTI I)
A Randomized, Double-blind, Comparative Trial to Evaluate the Efficacy, Safety and Tolerance of Combination Antiretroviral Regimens for Treatment of HIV-1 Infection: AZT/3TC vs AZT/3TC/Loviride in Antiretroviral Naïve Patients: Trial results
-
CTN 086: Isoniazid versus Rifabutin
A Phase III Controlled, Double-Blind, Randomized, Multinational Study for the Preventative Therapy of Latent Tuberculosis in HIV-positive Individuals: Isoniazid (300 mg/day x 12 months ) vs. Rifabutin (300 mg/day x 3 months)
-
CTN 083: LiGLA
A Phase I Open-Label Study of the Safety and Potential Efficacy of LiGLA (EF-13) in Advanced HIV Infection
-
CTN 081: 3TC, loviride, AZT
A Randomized, Controlled, Double-Blinded Trial to Compare the Efficacy and Safety of 3TC vs 3TC + Loviride vs Placebo in the Treatment of HIV-1-Infected Persons Taking Concurrent AZT Containing Treatment Regimens with CD4s between 25 and 250: Trial results
-
CTN 080: Hydroxyurea with ddI
A pilot study to assess the potential role of hydroxyurea as an adjuvant therapy among patients with advanced HIV disease receiving didanosine (ddI) therapy
-
CTN 067: Nevirapine, ddI, AZT
A randomized, placebo-controlled, double-blinded, multinational trial comparing the immunologic and virologic effects of nevirapine, ddI and AZT combinations for the treatment of antiretroviral naive HIV+ patients with 200 to 600 T-cells and no AIDS-defining disease: Trial results
-
CTN 057: NAC for TMP-SMX reactions
A Randomized Trial of the Use of N-acetylcysteine for the Prevention of Sulphonamide Hypersensitivity Reactions When Used for the Prevention of Pneumocystis Carinii Pneumonia in Patients with HIV infection: Trial results
-
CTN 047: AZT, ddI, ddC
Combination Therapy for Advanced HIV Disease: A Community-based Randomized Trial of the Safety and Laboratory Effects of ZDV/ddI vs ZDV/ddC
-
CTN 045: BV ara U, acyclovir
Evaluation of SQ32,756 (BV ara U) Versus Acyclovir in the Treatment of Localized Herpes Zoster in HIV Infected Patients
-
CTN 043: Whey Protein Supplementation
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
-
CTN 034: Erythropoietin deficiency in children
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
-
CTN 033: Rgp 160 vaccine (VaxSyn)
Active Immunization of Patients with HIV Infection: The Study of the Effect of VaxSyn on Progression of Immunodeficiency (gp160): Trial results
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More